TransMedics (TMDX) Free Cash Flow Growth (3y) (2021 - 2026)
TransMedics (TMDX) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | -29.89% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | -0.27% |
| 10 | TransMedics | 2.53 Bn | 2.07 Bn | 101.16 Mn | -8.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.14% |
| Dec 31, 2025 | 68.62% |
| Sep 30, 2025 | 46.89% |
| Jun 30, 2025 | 143.92% |
| Mar 31, 2025 | -15.61% |
| Dec 31, 2024 | 150.97% |
| Sep 30, 2024 | -126.37% |
| Jun 30, 2024 | 141.25% |
| Mar 31, 2024 | -86.52% |
| Dec 31, 2023 | -166.66% |
| Sep 30, 2023 | -2.34% |
| Jun 30, 2023 | 16.42% |
| Mar 31, 2023 | -4.98% |
| Dec 31, 2022 | 2.52% |
| Sep 30, 2022 | -57.39% |
| Jun 30, 2022 | 7.68% |
| Mar 31, 2022 | -37.79% |
| Dec 31, 2021 | -16.25% |
| Sep 30, 2021 | -14.30% |
| Jun 30, 2021 | 8.07% |